Muvalaplin

Overview

Muvalaplin (LY3473329) is an orally active, selective small molecule inhibitor of lipoprotein (a) ( Lp (a) ) that disrupts the initial non-covalent interaction between apo(a) and apoB100, preventing the disulphide bond and Lp(a) formation. Muvalaplin reduces the levels of Lp (a) in transgenic mice and in cynomolgus monkeys.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > LDLR

Product Information

• Catalog No.: HY-152857
• CAS No.: 2565656-70-2
• Molecular Formula: C42H54N4O6
• Molecular Weight: 710.90
• Purity: 99.96%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source